학술논문

Molecular Epidemiology of Tuberculosis among HIV-Infected Persons in Switzerland: A Countrywide 9-Year Cohort Study
Document Type
Author abstract
Source
Infection. Dec, 1999, Vol. 27 Issue 6, p323, 8 p.
Subject
Switzerland
Language
English
ISSN
0300-8126
Abstract
Byline: P. Sudre (1), G.E. Pfyffer (2), T. Bodmer (3), G. Prod'hom (4), H. Furrer (5), S. Basetti (6), E. Bernasconi (7), L. Matter (3), A. Telenti (8), A. Strassle (2), J.P. Jacques (1), R. Weber (9) Keywords: Key words IS6110; DNA fingerprinting; Molecular epidemiology; Tuberculosis; Transmission; HIV Abstract: We investigated tuberculosis transmission during a nine-year period (1988--1996) in an countrywide community-based cohort of HIV-infected persons in Switzerland (the Swiss HIV Cohort Study [SHCS]). We estimated the proportion of tuberculosis cases due to reinfection and relapse, and assessed factors which may increase the risk of tuberculosis transmission. HIV-infected persons were followed prospectively and molecular fingerprinting with insertion sequence (IS) 6110, 36-bp direct repeat, and IS6110-PCR was used to determine M. tuberculosis case clustering. Out of 7999 SHCS participants, 267 persons developed tuberculosis. 158 M. tuberculosis isolates from 138 patients were available for study. Molecular analysis identified 33 (24%) episodes of tuberculosis associated with 12 clusters including 2 to 8 patients. Two patients experienced reinfection, and nine had a relapse. Detailed contact investigation identified definite or possible epidemiological links between 21 of 33 cluster patients (64%). Multivariate logistic regression analysis did not identify any risk marker significantly associated with clustering. During a nine-year period, one fourth of tuberculosis case were grouped in clusters within a selection of 138 HIV-infected patients. This may represent the lowest estimation of recently acquired tuberculosis infection. There were no large institutional on community outbreaks among HIV-infected participants of the Swiss HIV Cohort Study. Author Affiliation: (1) University Hospital, Geneva Swiss HIV Cohort Study, Beaumont 6, CHUV, CH-1011, Lausanne, Switzerland, e-mail: PHILIPPE.SUDRE@HOSPVD.CH, CH (2) Institute of Medical Microbiology of the University of Zurich, National Reference Center for Mycobacteriology, Gloriastr. 3032, 8091 Zurich, Switzerland, CH (3) Institute of Medical Microbiology, University of Bern, 3010 Bern, Switzerland, CH (4) Institute of Medical Microbiology, CHUV. 1011 Lausanne, Switzerland, CH (5) HIV Sprechstunde, Med. Poliklinik, Inselspital, 3010 Bern, Switzerland, CH (6) Med. Universitats-Poliklinik, Kantonsspital Basel, Petersgraben 4, 4031 Basel, Switzerland, CH (7) Ambulatorio Malattie Infettive, Ospedale Civico, Via Tesserete 46, 6903 Lugano, Switzerland, CH (8) Division des maladies infectieuses, CHUV, 1011 Lausanne, Switzerland, CH (9) Division of Infectious Diseases, University Hospital, Ramistr. 100, 8091 Zurich, Switzerland, CH Article note: Received: May 18, 1999 * Accepted: October 5, 1999